Loading
Aclarion, Inc. Stock: price and insider trades · United States
6 insiders bought €109k of shares over the last 90 days, the latest filed 19 Aug 2026.
Aclarion, Inc.: what insiders have been doing
This page follows insider dealings at Aclarion, Inc. as filed with SEC (Form 4), a company from the Technology sector. The last twelve months, up to 18 October 2026, brought 18 filings signed by 10 insiders.
Only purchases show up on the open market, 9 purchases in all worth €131k, filed by 7 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 5 senior executives, 1 finance chief and 1 chief executive. At €43k, the purchase published on 17 August 2026 by Bond Ryan is the largest of the period (0.66% of market cap).
Across the 5,814 companies tracked on its exchange, the median is 19 filings; at 18 filings, this issuer sits below that mark. Over the whole record (from 2022), the tally stands at 16 purchases and no sales.
In all, 8 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 19 August 2026, which is 59 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4.
Other companies in the same sector with recent insider buying flagged by our signals: Core Scientific, Inc./tx and Gitlab Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€372,337
16 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBrent Ness2 buys
David K. Neal2 buys
Amanda M. Williams1 buy
Gregory A. Gould1 buy
Ryan Bond1 buy
Scott Breidbart1 buy
+1 other insider
Since the insiders bought
- -8.6%Entry US$2.69 · Close at T+30 US$2.46
- -9.0%Entry US$2.77 · Close at T+30 US$2.52
- +1.5%Entry US$2.60 · Close at T+30 US$2.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Aclarion, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$7.63.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,066 of 24,148 companies
4.1
score / 100
Value1
Quality7
FCF yld-131%
Earn yld-129%
EV/EBITDA·
ROE-59%
Gross mgn9.0%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2023FY ended December 2023 · cache
US$1.95
Analyst consensus
2 analystsStrong buy
US$7.50Target US$7.63(+290%)US$7.75
Income statement
RevenueUS$75.7k
Gross profitUS$6.8k9% margin
EBITDA-US$7M-9252% margin
Net income-US$7.2M-9560.7% margin
Valuation
PER (trailing)22.0x
PER (forward)-0.4x
P/Book0.3x
Beta1.21
Balance sheet & cash
Market capUS$5.6M
Total debtUS$1.1M
Free Cash Flow-US$7.4M
Debt / Equity6%
Profitability & ownership
ROE-59.0%
ROA-37.0%
% insiders24.0%
% institutions4.0%
Last declaration on 19 August 2026
Declarations29 total
5,857 shares@ US$2.730.21% mcap100.0% of flowCommon StockSEC:0001683168-26-006576:0
Canonical exit: 15 Nov 2026 (T+90)
10,000 shares@ US$2.450.32% mcap100.0% of flowCommon StockSEC:0001683168-26-006545:0
Canonical exit: 12 Nov 2026 (T+90)
7,500 shares@ US$2.400.24% mcap9.7% of flowCommon StockSEC:0001683168-26-006513:0
Canonical exit: 11 Nov 2026 (T+90)
5,234 shares@ US$2.310.16% mcap67.8% of flowCommon StockSEC:0001683168-26-006512:0
Canonical exit: 11 Nov 2026 (T+90)
2,150 shares@ US$2.340.067% mcap9.0% of flowCommon StockSEC:0001683168-26-006514:0
Canonical exit: 11 Nov 2026 (T+90)
20,000 sharesCommon StockSEC:0001683168-26-004812:0
20,000 sharesCommon StockSEC:0001683168-26-004806:0
100,000 sharesCommon StockSEC:0001683168-26-004807:0
20,000 sharesCommon StockSEC:0001683168-26-004809:0
20,000 sharesCommon StockSEC:0001683168-26-004810:0
100,000 sharesCommon StockSEC:0001683168-26-004811:0
20,000 sharesCommon StockSEC:0001683168-26-004814:0
50,000 sharesCommon StockSEC:0001683168-26-004813:0
5,664 shares@ US$3.180.0000% mcap100.0% of flowCommon StockSEC:0001683168-26-003744:0
Canonical exit: 10 Aug 2026 (T+90)
2,500 shares@ US$3.100.0000% mcap4.1% of flowCommon StockSEC:0001683168-26-003694:0
Canonical exit: 9 Aug 2026 (T+90)
10 shares@ US$6.200.3% of flowCommon StockSEC:0001683168-25-008777:0
Canonical exit: 24 Feb 2026 (T+90)
1 shares@ US$1,000.0049.7% of flowSeries A Preferred StockSEC:0001683168-23-001855:0
1 shares@ US$1,000.0050.3% of flowSeries A Preferred StockSEC:0001683168-23-001067:0
Canonical exit: 17 May 2023 (T+90)
4,100 shares@ US$0.43100.0% of flowCommon StockSEC:0001683168-22-008686:0
Canonical exit: 29 Mar 2023 (T+90)
2,289 shares@ US$0.425.8% of flowCommon StockSEC:0001683168-22-008688:0
Canonical exit: 28 Mar 2023 (T+90)
152,128 shares0Common StockSEC:0001683168-22-008267:0
1,091,894 shares0Common StockSEC:0001683168-22-008227:0
152,128 shares0Common StockSEC:0001683168-22-008226:0
25 of 29 declarations
About Aclarion, Inc.
Aclarion, Inc. is a technology company focused on developing health solutions based on artificial intelligence. It aims to improve clinical outcomes through advanced analytics.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
